Sun Pharma, NIV Tie-Up To Test Drugs For Zika, Chikungunya And Dengue


Pharma major, Sun Pharma and the National Institute of Virology, Pune announced on Tuesday that they have signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by the company against Zika, Chikungunya and Dengue viruses.

NIV is an institution of the Indian Council of Medical Research, Department of Health Research, Ministry of Health and Family Welfare.

Sun Pharma will provide drug molecules to NIV for testing against Zika, Chikungunya and Dengue in the model systems. Candidate molecules with encouraging data will then be taken forward for commercial development.

Sun Pharma and NIV aim to promote discovery sciences, translational health research and development of medical products, which is in sync with the direction provided by government’s ‘Make In India’ initiative.

Sun Pharma’s agreement with NIV follows its MoU with Indian Council of Medical Research (ICMR) for conducting joint scientific research and innovation.

Together, Sun Pharma and NIV will work together to respond to significant and emerging public health threats in India and rest of the world due to viruses including Zika, Chikungunya and Dengue. 

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔


Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: